X4 Pharmaceuticals, Inc. (XFOR) — 分析師展望 / 分析師共識目標價為. 基於 13 位分析師評級, 共識為 看漲 — 12 買入, 1 持有.
分析師共識目標價為 $10.00, 上漲空間為 138.1% 相對於當前價格 $4.20.
分析師預估 每股收益(EPS)為 $-3.90 和 營收為 $0.00B (下一財年).
每股收益(EPS)歷史表現: 2024: 實際 $-0.19 vs 預期 $-3.90 (超預期 +95.2%). 2025: 實際 $-1.87 vs 預期 $-2.04 (超預期 +8.2%). 分析師準確度: 0%.
XFOR 股票 — 12個月價格預測
$10.00
▲ +138.10% 上漲空間
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for X4 Pharmaceuticals, Inc., the price target is $10.00.
平均目標價相對最新價格 $4.20 變動 +138.10%。
XFOR 分析師評級
Buy
基於過去3個月內 13 位分析師對 X4 Pharmaceuticals, Inc. 的評級
EPS 預測 — XFOR
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.19
vs Est –$3.90
▲ 1,996.8% off
2025
Actual –$1.87
vs Est –$2.04
▲ 9.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
營收預測 — XFOR
92%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.002B
▲ 14.0% off
2025
Actual $0.035B
vs Est $0.034B
▲ 2.5% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
